learningandfinance.com


Medical

DEA Refuses to Scale Back Fed. Restrictions On Marijuana

Share

"Schedule I drugs are the most risky drugs of all the drug schedules with potentially severe psychological or physical dependence".

The U.S. government will announce on Thursday that it will allow more research into marijuana but has rejected requests to relax the classification of the substance as a unsafe, highly addictive drug with no medical use, sources with direct knowledge of the matter said.

The DEA's decision will be published Friday in the Federal Register.

However, the DEA did, in a separate proposal also issued Thursday, announce a policy change that may increase the amount of research conducted on marijuana.

In a column published Friday on CNN.com, the renowned physician and chief medical correspondent voiced his displeasure over the DEA's actions this week to lift restrictions on marijuana research while failing to reschedule cannabis from its current Schedule I classification. Now only researchers at the University of MS have the government's permission to grow pot.

Under the Controlled Substances Act, marijuana is considered a Schedule I drug - as are heroin, LSD and ecstasy.

The Drug Enforcement Administration is standing firm on marijuana.

Vikings @ Bengals, Preseason Game #1
The difference? Treadwell caught 82 balls for more than 1,100 yards past year with 11 touchdowns while Core went 37, 644, four. The Vikings were fifth previous year with 18.9 points allowed per game. "I'd like to thank Minnesota State", Zimmer said.

Islamic State announces new Boko Haram leader
ISIS, the report said, did not say what happened to Shekau who has been out of the picture since 2015. Al-Barnawi, who has been named as Boko Haram's new leader, is something of a mystery.

Philippines to Pursue 'Formal Talks' With China
Tokyo lodged a series of protests over the weekend regarding renewed Chinese activity in the disputed East China Sea. We have to go back to Manila to find out what are the latest developments on the official side.

The agency said it has never stood in the way of a researcher conducting an FDA-approved study using marijuana from the NIDA-approved supply of the plant.

Despite that, more than two dozen states and Washington D.C. have laws allowing for medical use of the drug. "If those studies show medical value, marijuana rescheduling will be more likely".

An employee places marijuana for sale into glass containers at The Station, a retail and medical cannabis dispensary, in Boulder, Colo., Thursday, Aug. 11, 2016.

"As states continue to legalize medical and recreational marijuana across the country, there is more that the federal government must to do to provide states with legal certainty and empower the operation of safe systems across the country". More than half the states have legalized the drug for either medicinal or recreational use.

For years, the University of MS has been the only institution authorized to grow the drug for use in medical studies.

Despite that, proponents of medical marijuana research welcome the federal government's decision to allow more universities to grow the drug.

Share